½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹VANGL1¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹VANGL1¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW2319
    • Ó¦Óà : ½öÏÞÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£ºÍÿ¹VANGL1¶à¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ£º Anti-VANGL1 rabbit polyclonal antibody

±ð      Ãû£º LPP2; STB2; STBM2; KITENIN

´¢      ´æ£º Àä¶³£¨-20¡æ£©

¿¹      Ô­£º VANGL1

ËÞ      Ö÷£º Rabbit

Ïà¹ØÀà±ð£º Ò»¿¹

·´Ó¦ÖÖÊô£º Human, Mouse

±ê  ¼Ç  Î Unconjugate

¿Ë¡ÀàÐÍ£º rabbit polyclonal

¼¼Êõ¹æ¸ñ

Background:

This gene encodes a member of the tretraspanin family. The encoded protein may be involved in mediating intestinal trefoil factor induced wound healing in the intestinal mucosa. Mutations in this gene are associated with neural tube defects. Alternate splicing results in multiple transcript variants. Interacts through its C-terminal region with the N-terminal half of DVL1, DVL2 and DVL3. The PDZ domain of DVL1, DVL2 and DVL3 is required for the interaction.

Applications:

ELISA, WB, IHC

Name of antibody:

VANGL1

Immunogen:

Fusion protein of human VANGL1

Full name:

VANGL planar cell polarity protein 1

Synonyms£º

LPP2; STB2; STBM2; KITENIN

SwissProt:

Q8TAA9

ELISA Recommended dilution:

1000-2000

IHC positive control:

Human cervical cancer and human thyroid cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

60 kDa

WB Positive control:

Hela cells

WB Recommended dilution:

200-1000




¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿